Cytokinetics, Incorporated · NASDAQ:CYTK

Wierenga Wendell received 97 Cytokinetics, Incorporated shares as an award (Form 4)

Traded Oct 16, 2026 · Filed Oct 20, 2026

On Oct 16, 2026, Wierenga Wendell (Director) received 97 Cytokinetics, Incorporated shares as an award at US$63.92 for US$6,200, leaving 35,660 shares. Filed Oct 20, 2026 (Form 4).

Awarded
97 shares
Price
US$63.92
Value
US$6,200
Holding after
35,660 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 16, 2026Common StockAward97US$63.9235,660Direct

Source

Download original · View original at SEC

Related